Last update:

Medications news

Medications

FDA to ease copycat drug rules, speeding access to cheaper drugs

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to cheaper alternatives.

Medications

Q&A: The economic forces that drive prescription drug prices

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.

Medications

Chemists design candidate drug against diabetes

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

Medications

New imaging technique maps drug movement through skin in minutes

By combining mass spectrometry imaging with an automated analysis tool, researchers from Hebrew University have developed a technique that maps medication distribution across skin layers without dyes or labels. Tested on ...

Medications

Why a promising ALS drug failed—despite hitting its target

A new Emory University study, led by the Emory ALS Center and the Center for Neurodegenerative Disease at Emory's Goizueta Brain Health Institute, sheds light on why a once-promising experimental medication for amyotrophic ...

Medications

FDA expands use of Vonvendi for von Willebrand disease

The U.S. Food and Drug Administration has approved expanded use of Vonvendi (von Willebrand factor [recombinant]) for routine prophylactic use in adults with all types of the blood-clotting disorder von Willebrand disease ...

Medications

WHO backs weight-loss drugs, urges cheap generics

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in ...